iShares U.S. Pharmaceuticals ETF (IHE)
NYSEARCA: IHE · Real-Time Price · USD
85.92
+0.07 (0.08%)
Nov 26, 2025, 4:00 PM EST - Market closed
IHE Holdings Information
IHE is an equity ETF with a total of 47 individual holdings. The top holdings are Eli Lilly and Company stock at 27.24%, Johnson & Johnson at 21.78%, Merck & Co. at 4.66%, Royalty Pharma at 4.05%, and Pfizer at 3.88%.
Total Holdings
25
Top 10 Percentage
79.44%
Asset Class
Equity
ETF Category
Health
Assets
761.18M
PE Ratio
22.90
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 27.24% |
| 2 | JNJ | Johnson & Johnson | 21.78% |
| 3 | MRK | Merck & Co., Inc. | 4.66% |
| 4 | RPRX | Royalty Pharma plc | 4.05% |
| 5 | PFE | Pfizer Inc. | 3.88% |
| 6 | BMY | Bristol-Myers Squibb Company | 3.85% |
| 7 | VTRS | Viatris Inc. | 3.82% |
| 8 | ELAN | Elanco Animal Health Incorporated | 3.61% |
| 9 | JAZZ | Jazz Pharmaceuticals plc | 3.39% |
| 10 | ZTS | Zoetis Inc. | 3.17% |
| 11 | CORT | Corcept Therapeutics Incorporated | 2.33% |
| 12 | AXSM | Axsome Therapeutics, Inc. | 1.95% |
| 13 | CRNX | Crinetics Pharmaceuticals, Inc. | 1.31% |
| 14 | LGND | Ligand Pharmaceuticals Incorporated | 1.24% |
| 15 | TARS | Tarsus Pharmaceuticals, Inc. | 0.95% |
| 16 | PBH | Prestige Consumer Healthcare Inc. | 0.90% |
| 17 | SUPN | Supernus Pharmaceuticals, Inc. | 0.80% |
| 18 | AVDL | Avadel Pharmaceuticals plc | 0.69% |
| 19 | LQDA | Liquidia Corporation | 0.68% |
| 20 | AMRX | Amneal Pharmaceuticals, Inc. | 0.65% |
| 21 | OCUL | Ocular Therapeutix, Inc. | 0.64% |
| 22 | OGN | Organon & Co. | 0.60% |
| 23 | NUVB | Nuvation Bio Inc. | 0.59% |
| 24 | PRGO | Perrigo Company plc | 0.55% |
| 25 | EWTX | Edgewise Therapeutics, Inc. | 0.55% |
As of Nov 25, 2025